The purpose of the clinical trial is to find a treatment for stroke patients with cognitive impairment, and the main questions it aims to answer are: * \[Search for effective treatments of cognitive impairment after stroke\] * \[explore the relationship between BDNF level and cognitive function\] Participants will receive conventional treatment, tDCS treatment, .And then compare cognitive function and BDNF level
1. To study the therapeutic effect of transcranial direct current stimulation (tDCS) on post-stroke cognitive impairment (PSCI) by evaluating cognitive function and detecting plasma brain-derived neurotrophic factor (BDNF). 2. To explore the correlation between plasma BDNF level and cognitive function in patients with PSCI.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
40
Both groups were given routine treatment
The common group routine training used sham TDCS stimulation, and the experimental group used real TDCS stimulation
Department of Rehabilitation Medicine, the Second Hospital of Dalian Medical University
Dalian, Liaoning, China
COMPLETEDLily
Dalian, Liaoning, China
RECRUITINGBDNF
Plasma BDNF was determined by elisa
Time frame: 2 weeks
Cognitive function level
Score of Mini-Mental State Examination(MMSE) and Montreal Cognitive Assessment(MoCA)
Time frame: 2 weeks
Executive function level
core of The Frontal Assessment Battery(FAB)
Time frame: 2 weeks
Memory function level
Score of Rivermead Behavioral Memory Test(RBMT)
Time frame: 2 weeks
Ren
CONTACT
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.